Table 2.
2018/2019 (n = 66) | 2019/2020 (n = 96) | 2020/2021 (n = 16) | |
---|---|---|---|
n (%) | n (%) | n (%) | |
Influenza A | 11 (17) | 2 (2) | 0 (0) |
Influenza B | 0 (0) | 4 (4) | 0 (0) |
Adenovirus | 4 (6) | 10 (10) | 2 (12) |
Bocavirus | 8 (12) | 7 (7) | 2 (12) |
Coronavirus (non SARS-CoV-2) | 3 (5) | 1 (1) | 0 (0) |
Enterovirus | 3 (5) | 7 (7) | 1 (6) |
Metapneumovirus | 4 (6) | 12 (12) | 0 (0) |
Parainfluenza viruses (1;3;4) | 0 (0) | 7 (7) | 0 (0) |
Rhinovirus | 13 (20) | 21 (22) | 14 (87) |
RSV | 46 (70) | 62 (65) | 0 (0) |
CMV | 2 (3) | 0 (0) | 1 (6) |
SARS-CoV-2 | 0 (0) | 0 (0) | 2 (12) |
CMV, cytomegalovirus; RSV, respiratory syncytial virus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.